What is a Challenging Clot?: A DELPHI Consensus Statement from the CLOTS 7.0 Summit von Ospel, Johanna M., Mirza, Mahmood, Clarençon, Frédéric, Siddiqui, Adnan, Doyle, Karen, Consoli, Arturo, Mokin, Maxim, Ullberg, Teresa, Zaidat, Osama, Bourcier, Romain, Kulcsar, Zsolt, Gounis, Matthew J., Liebeskind, David S., Fiehler, Jens, Narata, Ana Paula, Ribo, Marc, Jovin, Tudor, Sakai, Nobuyuki, Rai, Ansaar, McCarthy, Ray, Dorn, Franziska, Andersson, Tommy, Majoie, Charles B. L. M., Hanel, Ricardo, Jadhav, Ashutosh, Riedel, Christian, Chamorro, Angel, Brinjikji, Waleed, Costalat, Vincent, DeMeyer, Simon F., Nogueira, Raul G., Cognard, Christophe, Montaner, Joan, Leung, Thomas W., Molina, Carlos, van Beusekom, Heleen, Davalos, Antoni, Weisel, John, Chapot, Rene, Möhlenbruch, Markus, Brouwer, Patrick

Volltext

Efficacy and Safety of Tifacogin (Recombinant Tissue Factor Pathway Inhibitor) in Severe Sepsis: A Randomized Controlled Trial von Abraham, Edward, Reinhart, Konrad, Opal, Steven, Demeyer, Ignace, Doig, Christopher, Rodriguez, Angel López, Beale, Richard, Svoboda, Petr, Laterre, Pierre Francois, Simon, Stuart, Light, Bruce, Spapen, Herbert, Stone, Judy, Seibert, Allan, Peckelsen, Claus, De Deyne, Cathy, Postier, Russell, Pettilä, Ville, Sprung, Charles L, Artigas, Antonio, Percell, Sandra R, Shu, Vincent, Zwingelstein, Christian, Tobias, Jeffrey, Poole, Lona, Stolzenbach, James C, Creasey, Abla A

Volltext

Efficacy and safety of a phospholipid emulsion (GR270773) in Gram-negative severe sepsis: Results of a phase II multicenter, randomized, placebo-controlled, dose-finding clinical t... von Phillip Dellinger, R, Tomayko, John F, Angus, Derek C, Opal, Steven, Cupo, Michael A, McDermott, Sharon, Ducher, Annie, Calandra, Thierry, Cohen, Jonathan

Volltext